Iressa Tablets 250, manufactured by AstraZeneca (YJ code: 4291013F1027, standard: 250mg x 1 tablet), contain gefitinib, a tyrosine kinase inhibitor used for the first-line treatment of metastatic non-small cell lung cancer with specific EGFR mutations.
Iressa Tablets 250
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
More with the same ingredient
